Table 1.
Clinical and demographic characteristics of patients and individuals participating in the study.
Variable | HD n = 17 |
AKI(-) n = 17 |
AKI(+) n = 17 |
---|---|---|---|
Gender,n(%) | |||
Male | 16 (94) | 14 (82) | 15 (88) |
Female | 1 (6) | 3 (18) | 2 (12) |
Age (years, median (IQR)) | 31 [23–63] | 39 [24–57] | 42 [22–39] |
Occurrence zone,n(%) | |||
Rural | — | 16 (94) | 15 (88) |
Urban | — | 1 (6) | 2 (12) |
Bite classification,n(%) | |||
Mild | — | 17 (100) | — |
Severe | — | — | 17 (100) |
Anatomical site of the bite,n(%) | |||
Upper limbs | — | 5 (29) | 4 (23) |
Lower limbs | — | 12 (71) | 13 (77) |
Previous snakebite,n(%) | |||
Yes | — | 3 (18) | — |
No | — | 14 (82) | 17 (100) |
Adverse reaction to antivenom,n(%) | |||
Yes | — | 2 (12) | 3 (18) |
No | — | 15 (88) | 14 (82) |
Comorbidities,n(%) | |||
Yes | — | 1 (6) | 4 (23) |
No | — | 16 (94) | 13 (77) |
Time to medical assistance (hours,n(%)) | |||
0 – 3 | — | 12 (71) | 10 (59) |
4 – 6 | — | 5 (29) | 2 (12) |
>6 | — | — | 5 (29) |
Time to development of AKI (hours,n(%)) | |||
≤24 | — | — | 10 (59) |
>24 | — | — | 7 (41) |